India to build future-ready drug regulatory framework to accelerate healthcare innovation, Says J P Nadda Read more
Trump’s proposed generic drug tariffs trigger caution, industry sees limited near-term impact Read more
PHARMEXCIL engages in high-level meetings to discuss roadmap for India’s generic pharma exports Read more
Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026 Read more
Piyush Goyal inaugurates iPHEX 2025; underlines India’s position as ‘Pharmacy of the World’ Read more